Most recently, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to the big selection of endogenous opioids. As opposed to most opioid receptors, this receptor functions being a scavenger https://abrahamt086qst7.wikistatement.com/user